Combined antiviral therapy reduces HIV-1 plasma load and improves CD4 counts but does not interfere with ongoing lymphocyte apoptosis

Immunopharmacology and Immunotoxicology

Volumn 21, Issue 4, 1999, Pages 645-665

  Moretti, Sonia ^a   Alesse, Edoardo ^a   Marcellini, Sonia ^a   Di Marzio, Luisa ^a   Zazzeroni, Francesca ^a   Parroni, Raffaella ^a   Famularo, Giuseppe ^a   Boschini, Antonio ^a   Cifone, Maria Grazia ^a   De Simone, Claudio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; DIDANOSINE; ZIDOVUDINE;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIREMIA; VIRUS LOAD;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032758573     PISSN: 08923973     EISSN: None     Source Type: Journal    
DOI: 10.3109/08923979909007132     Document Type: Article

References (65)

1. Mellors, J.W., Rinaldo, C.R. Jr., Gupta, P., White, R.M., Todd, J.A., and Kingsley, L.A., Prognosis In HIV-1 Infection Predicted By The Quantity Of Virus In Plasma. Science, 272: 1167, 1996.
2. Mellors, J.W., Kingsley, L.A., Rinaldo, C.R. Jr. et al., Quantitation Of HIV-1 RNA In Plasma Predicts Outcome After Seroconversion. Ann. Intern. Med., 122: 573, 1995.
3. Jurriaans, S., Van Gemen, B., Weverling, G.J. et al., The Natural History Of HIV-1 Infection: Virus Load And Virus Phenotype Independent Determinants Of Clinical Course? Virology, 204: 223, 1994.
4. Henrard, D.R., Philips, J.F., Muenz, L.R. et al., Natural History Of HIV-1 Cell-free Viremia. JAMA, 274: 554, 1995.
5. Fauci, A.S., Pantaleo, G., Stanley, S. and Weissman, D., Immunopathogenic Mechanisms Of HIV Infection. Ann. Intern. Med., 124: 654, 1996.
6. Pantaleo, G., Graziosi, C., Demarest, J.F. et al., HIV Infection Is Active And Progressive In Lymphoid Tissue During The Clinically Latent Stage Of Disease. Nature, 362: 355, 1993.
7. Faust, R.A., Henry, K., Dailey, P. et al., Outpatient Biopsies Of The Palatin Tonsil: Access To Lymphoid For Assessment Of Human Immunodeficiency Virus RNA Titers. Otolaryngol. Head Neck. Surg., 114: 593, 1996.
8. Lafeuillade, A., Poggi, C., Profizi, N., Tamalet, C. and Costes, O., Human Immunodeficiency Virus Type 1 Kinetics In Lymph Nodes Compared With Plasma. J. Infect. Dis., 174: 404, 1996.
9. Cohen, O.J., Pantaleo, G., Holodniy, M. et al., Decreased Human Immunodeficiency Virus Type 1 Plasma Viremia During Antiretroviral Therapy Reflects Down Regulation Of Viral Replication In Lymphoid Tissue. Proc. Natl. Acad. Sci. USA, 92: 6017, 1995.
10. Cohen, O.J., Pantaleo, G., Holodniy, M. et al., Antiretroviral Monotherapy In Early Stage Human Immunodeficiency Virus Disease Has No Detectable Effect On Virus Load In Peripheral Blood And Lymph Nodes. J. Infect. Dis., 173: 849, 1996.
11. Erice, A., Daileym P., Haasem A., et al., HIV RNA Levels In Lymphoid Tissue, Peripheral Blood Leukocytes (PBMC) And Plasma (PL) Fractions Of HIV-Infected Individuals [abstract 260]. In: Program and abstracts of the Third Conferences on Retroviruses and Opportunistic Infections (Washington, D.C.). Aexandria, Virginia: Infectious Diseases Society of America, 1996.
12. Meylan, P.R.A., Burgisser, P., Weyrich-Suter, C. and Spertini, F., Viral Load And Immunophenotype Of Cells Obtained From Lymph Nodes By Fine Needle Aspiration As Compared With Peripheral Blood Cells In HIV-Infected Patients. J. Acquired Immune Defic. Syndr., 13: 39, 1996.
13. De Gruttola, V., Fleming, T., Lyn, D.Y. and Coombs, R., Validating Surrogate Markers. Are We Being Naive? J. Infect. Dis., 175: 237, 1997.
14. Fessel, W.J., Human Immunodeficiency Virus (HIV) RNA In Plasma As The Preferred Target For Therapy In Patients With HIV Infection: A Critique. Clin. Infect. Dis., 24: 116, 1997.
15. Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M. and Markowitz, M., Rapid Turnover Of Plasma Virions And CD4 Lymphocytes In HIV-1 Infection. Nature, 373: 123, 1995.
16. Wei, X., Ghosh, S.K., Taylor, M.E., et al., Viral Dynamic In Human Immunodeficiency Virus Type 1 Infection. Nature, 373: 117, 1995.
17. Perelson, A.S., Neumann, A.U., Markowitz, M., Leonard, J.M. and Ho, D.D., HIV-1 Dynamic In Vivo: Virion Clearance Rate, Infected Cell Life-Span, And Viral Generation Time. Science, 271: 1582, 1996.
18. Finkel, T.H., Tudor-Williams, G., Banda, N.K, et al., Apoptosis Occurs Predominantly In Bystander Cells And Not In Productively Infected Cells Of HIV-And SIV-Infected Lymph Nodes. Nat. Med., 2: 129, 1995.
19. Bofill, M., Gombert, W., Borthwick, N.J. et al., Presence Of CD3+ CD8+ Bcl-2 Low Lymphocytes Undergoing Apoptosis And Activated Macrophages In Lymph Nodes Of HIV-1+ Patients. Am. J. Pathol., 146: 1542, 1995.
20. Muro-Cacho, C.A., Pantaleo, G. and Fauci, A.S., Analysis Of Apoptosis In Lymph Nodes Of HIV-Infected Persons: Intensity Of Apoptosis Correlates With The General State Of Activation Of The Lymphoid Tissue And Not With The Stage Of Disease Or Viral Burden. J. Immunol., 154: 5555, 1995.
21. Meyaard, L., Otto, S.A., Jonker, R.R., Mijnster, M.J., Keet, R.P. and Miedema, F., Programmed Death Of T Cells In HIV-1 Infection. Science, 257: 217, 1992.
22. Groux, H., Torpier, G., Monte, D., Mouton, Y., Capron, A. and Ameisen, J.C., Activation-Induced Death By Apoptosis In CD4+ T Cells From Human Immunodeficiency Virus-Infected Asymptomatic Individuals. J. Exp. Med. 175: 331, 1992.
23. Gougeon, M.L. and Montagnier, L., Apoptosis In AIDS. Science, 260: 1269, 1993.
24. Gougeon, M.L., Garcia, S., Heeney, J., Tschopp, R. et al., Programmed Cell Death In AIDS-Related HIV And SIV Infections. AIDS Res. Hum. Retroviruses, 9: 553, 1993.
25. Lewis, D.E., Ng Tang, D.S., Adu-Oppong, A., Schober, W. And Rodgers, J.R., Anergy And Apoptosis In CD8+ T Cells From HIV-Infected Persons. J. Immunol., 153: 412, 1994.
26. Gougeon, M.L., Lecoeur, H., Dulioust, A. et al., Programmed Cell Death In Peripheral Lymphocytes From HIV-Infected Persons: The Increased Susceptibility To Apoptosis Of CD4 And CD8 T Cells Correlates With Lymphocyte Activation And With Disease Progression. J. Immunol., 156: 3509, 1996.
27. Boudet, F., Lecoeur, H. and Gougeon, M.L., Apoptosis Associated With Ex Vivo Downregulation Of Bcl-2 And Upregulation Of Fas In Potential Cytotoxic CD8+ T Lymphocytes. J. Immunol., 156: 2282, 1996.
28. De Simone, C., Cifone, M.G., Di Marzio, L. et al., Cell-Associated Ceramide In HIV-1-Infected Subjects. AIDS, 10: 675, 1996.
29. De Simone, C., Famularo, G., Cifone, M.G. and Mitsuya, H., HIV-1 Infection And Cellular Metabolism. Immunol. Today, 17: 256, 1996.
30. Katsikis, P.D., Wunderlich, E.S., Craig, C.A. and Herzenberg, L.A., Fas Antigen Stimulation Induced Marked Apoptosis Of T Lymphocytes In HIV Virus-Infected Individuals. J. Exp. Med., 181: 2029, 1995.
31. Aries, S.P., Schaaf, B., Muller, C., Dennin, R.H. and Dalhoff, K., Fas (CD95) Expression On CD4+ T Cells From HIV-Infected Patients Increases With Disease Progression. J. Mol. Med., 73: 591, 1995.
32. Silvestris, F., Cafforio, P., Frassanito, F.A. et al., Overexpression Of Fas Antigen On T Cells In Advanced HIV-1 Infection: Differential Ligation Constantly Induces Apoptosis. AIDS, 10: 131, 1996.
33. Sloand, E.M., Young, N.S., Kumar, P., Weichold, F.F., Sato, T. and Maciejewski, J.P., Role Of Fas Ligand And Receptor In The Mechanism Of T-Cell Depletion In Acquired Immunodeficiency Syndrome: Effect On CD4+ Lymphocyte Depletion And Human Immunodeficiency Virus Replication. Blood, 89: 1357, 1997.
34. Debatin, K.M., Fahrig-Faissner, A., Enenkel-Stoodt, S., Kreuz, W., Benner, A. and Krammer, P.H., High Expression Of APO-1 (CD95) On T Lymphocytes From Human Immunodeficiency Virus-1-Infected Children. Blood, 83: 3101, 1994.
35. McCloskey, T.W., Oyaizu, N., Kaplan, M. and Pahwa, S., Expression Of The Fas Antigen In Patients Infected With Human Immunodeficiency Virus. Cytometry, 22: 111, 1995.
36. Oyaizu, N., McCloskey, T.W., Than, S., Hu, R. and Pahwa, S., Mechanisms Of Apoptosis In Peripheral Blood Mononuclear Cells Of HIV-Infected Patients. Adv. Exp. Med. Biol., 374: 101, 1995.
37. Estaquier, J., Tanaka, M., Suda, T., Nagata, S., Golstein, P. and Ameisen, J.C., Fas-Mediated Apoptosis Of CD4+ And CD8+ T Cells From Human Immunodeficiency Virus-Infected Persons: Differential In Vitro Preventive Effect Of Cytokines And Protease Antagonists. Blood, 87: 4959, 1996.
38. Gougeon, M.L., Lecoeur, H., Boudet, F. et al., Lack Of Chronic Immune Activation In HIV-Infected Chimpanzees Correlates With The Resistance Of T Cells To Fas/Apo-1 (CD95)-Induced Apoptosis And Preservation Of A T Helper 1 Phenotype. J. Immunol., 158: 2964, 1997.
39. Gehri, R., Hahn, S., Rothen, M., Steuerwald, M., Nuesch, R. and Erb, P., The Fas Receptor In HIV Infection: Expression On Peripheral Blood Lymphocytes And Role In The Depletion Of T Cells. AIDS, 10: 9, 1996.
40. Westendorp, M.O., Frank, R., Oschsenbauer, C. et al., Sensitization Of T Cells To CD95-Mediated Apoptosis By HIV-1 Tat And gp120. Nature, 375: 497, 1995.
41. Nagata, S., Apoptosis by death factor: Cell, 88: 355, 1997.
42. Cifone, M.G., De Maria, R., Roncaioli, P. et al., Apoptotic Signaling Through CD95 (Fas/Apo-1) Activates An Acidic Sphingomyelinase. J. Exp. Med., 177: 1547, 1994.
43. Cifone, M.G., Roncaioli, P., De Maria, R. et al., Multiple Pathways Originate At The Fas/Apo-1 (CD95) Receptor: Sequential Involvement Of Phosphatidylcholine-Specific Phospholipase C And Acidic Sphingomyelinase In The Propagation Of The Apoptotic Signal. EMBO J., 14: 5859, 1995.
44. Westendorp, M.O., Shatrov, V.A., Schultze-Osthoff, K. et al., HIV-1 Tat Potentiates TNF-Induced NF-kB Activation And Cytotoxicity By Altering The Cellular Redox State. EMBO J., 14. 546, 1995.
45. Schreck, R., Rieber, P. and Bauerle, P.A., Reactive Oxygen Intermediates As Apparently Widely Used Messengers In The Activation Of The NF-kB Transcription Factor And HIV-1. EMBO J., 10: 2247, 1991.
46. Greenspan, H.C. and Aruoma, O.I., Oxidative Stress And Apoptosis In HIV Infection: A Role For Plant-Derived Metabolites With Synergistic Antioxidant Activity. Immunol. Today, 15: 209, 1994.
47. Boyum, A., Isolation Of Mononuclear Cells And Granulocytes From Human Blood. Scand. J. Clin. Invest., 97 (Suppl 21): 77, 1968.
48. Nicoletti, I., Migliorati, G., Pagliacci, C., Grignani, F. and Riccardi, C., A Rapid And Simple Method For Measuring Thymocyte Apoptosis By Propidium Iodide Staining And Flow Cytometry. J. Immunol. Methods, 139: 271, 1968.
49. Schmid, I., Uittenbogaart, C.H., Keld, B. and Giorgi, J.V., A Rapid Method For Measuring Apoptosis And Dual-Color Immunofluorescence By Single Laser Flow Cytometry. J. Immunol. Methods, 170: 145, 1994.
50. Zamzami, N., Marchetti, P., Castedo, M. et al., Reduction In Mitochondrial Potential Constitutes An Early Irreversible Step Of Programmed Lymphocyte Death In Vivo. J. Exp. Med., 181: 1661, 1995.
51. Rothe, G. and Valet, G., Flow Cytometric Analysis Of Respiratory Burst Activity In Phagocytes With Hydroethidine And 2', 7'-Dichlorofluorescin. J. Leukoc. Biol., 47: 440, 1990.
52. Wyllie, A.N., Morris, R.G., Smith, A.L. and Dunlop, D., Chromatin Cleavage In Apoptosis: Association With Condensed Chromatin Morphology And Dependence On Macromolecular Synthesis. J. Pathol., 142: 67, 1991.
53. Dive, C., Gregory, C.D., Phipps, D.J., Evans, D.L., Milner, A.E. and Wyllie, A.H., Analysis And Discrimination Of Necrosis And Apoptosis (Programmed Cell Death) By Multiparameter Flow Cytometry. Biochim. Biophys. Acta, 1133: 275, 1992.
54. Kroemer, G., Zamzami, N. and Susin, S.A., Mitochondrial Control Of Apoptosis. Immunol. Today, 18: 44, 1997.
55. Sailaja, G., Nayak, R. and Antony, A., Azidothymidine Induces Apoptosis In Mouse Myeloma Cell Line sp2/0. Biochem. Pharmacol., 52: 857, 1996.
56. Cordiali-Fei, P., Solmome, M., Viora, M. et al., Apoptosis In HIV Infection: Protective Role Of IL-2. Biol. Regul. Homeost. Agents, 8: 60, 1994.
57. Zamzami, N., Marchetti, P., Castedo, M. et al., Sequential Reduction Of Mitochondrial Transmembrane Potential And Generation Of Reactive Oxygen Species In early Programmed Cell Death. J. Exp. Med., 182: 367, 1995.
58. Petit, P.X., LeCoeur, H., Zorn, E., Dauguet, C., Mignotte, B. and Gougeon, M.L., Alterations Of Mitochondrial Structure And Function Are Early Events Of Dexamethasone-Induced Thymocyte Apoptosis. J. Cell. Biol., 130: 157, 1995.
59. Heeney, J., Jonker, J., Koornstra, W. et al., The Resistance Of HIV-Infected Chimpanzees To Progression To AIDS Correlates With Absence Of HIV-Related Dysfunction. J. Med. Primatol., 22: 194, 1993.
60. Estaquier, J., Idziorek, T., de Bels, F. et al., Programmed Cell Death And AIDS: Significance Of T Cell Apoptosis In Pathogenic And Nonpathogenic Primate Lentiviral Infections. Proc. Natl. Acad. Sci. USA, 91: 9341, 1994.
61. Moretti, S., Marcellini, S., Boschini, A. et al., Apoptosis And Apoptosis-Associated Perturbations Of Peripheral Blood Lymphocytes During HIV Infection: Comparison Between AIDS Patients And Long-Term Nonprogressors. (submitted)
62. Cohen, D.A., Fitzpatrick, E.A., Barve, S.S. et al., Activation-Dependent Apoptosis In CD4+ T Cells During Murine AIDS. Cell. Immunol., 151: 392, 1993.
63. Willett, B.J., Flynnm J.N. and Hosie, M.J., FIV Infection Of The Domestic Cat: An Animal Model For AIDS. Immunol. Today, 18: 182, 1997.
64. Kovacs, J.A., Vogel, S., Albert, J.M. et al., Controlled Trial Of Interleukin-2 Infusions In Patients Infected With Human Immunodeficiency Virus. N. Engl. J. Med., 335: 1350, 1996.
65. Davey, R.T. Jr., Chaitt, D.G., Piscitelli, S.C. et al., Subcutaneous Administration Of Interleukin-2 In Human Imunodeficiency Virus Type 1-Infected Persons. J. Infect. Dis., 175: 781, 1997.